Europe Gelatin and Bone Glue Market

Europe Gelatin and Bone Glue Market, By Product Type (Gelatin (Acidic Pretreatment and Alkali Pretreatment) and Bone Glues (Synthetic Bone Glues and Natural Bone Glues), By Application (Arthroplasty, Sports Injuries, Spine Surgery, Trauma, and Others), and By End user (Hospitals, specialty clinics, and ambulatory surgical centers), and By Country (Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Gelatin is obtained from collagen, which present in the ligaments, tendons, and tissues of mammals. Gelatin is used as bone void fillers, hemostatic sponges, and biodegradable orthopedic implants. There are two types of bone glues used synthetic and natural bone glues respectively. Increasing number of joint replacement procedures is expected to propel growth of Europe gelatin and bone glue market over the forecast period. Furthermore, increasing cases of sports-related injuries is expected is also anticipated to assist the growth of the market during the forecast period.

Market Dynamics

The gelatin and bone glue market is driven by demand from pharmaceuticals, food and beverages, healthcare, and cosmetics. Gelatin and bone glue offer versatile applications in these industries, including its use in pharmaceutical formulations, surgical adhesives, and collagen-rich products. However, challenges arise from the emergence of plant-based alternatives and the need for compliance with stringent regulations. Nonetheless, the market continues to thrive due to the inherent properties and benefits of gelatin and bone glue, making them indispensable in various sectors.

On March 13, 2023, a UCLA-led research team introduced a biodegradable hydrogel adhesive inspired by mussels, offering a strong and precise solution for sealing surgical wounds. The adhesive, injected from a syringe, demonstrated three times the strength of comparable bioglues and exhibited a honey-like viscosity for effective sealing of curved and wet tissues. Taking cues from mussels' ability to adhere to wet surfaces, the team modified gelatin with catechols, enhancing its adhesive properties.

On November 26, 2022, RevBio, Inc. initiated an experiment onboard the International Space Station (ISS) to study TETRANITE, a regenerative bone adhesive biomaterial. The research aims to assess TETRANITE's ability to regenerate bone under microgravity conditions simulating osteoporosis. The study materials were launched as part of SpaceX's 26th Commercial Resupply Services mission.

Key features of the study:

• This report provides in-depth analysis of the Europe gelatin and bone glue market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2023–2020), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Europe gelatin and bone glue market based on the following parameters– company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include, Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical, Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Europe gelatin and bone glue market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe gelatin and bone glue market

Detailed Segmentation:

• Europe Gelatin and Bone Glue Market, By Product Type:
• Gelatin
• Acidic Pretreatment
• Alkali Pretreatment
• Bone Glues
• Synthetic Bone Glues
• Natural Bone Glues
• Europe Gelatin and Bone Glue Market, By Application:
• Arthroplasty
• Sports Injury
• Spine Surgery
• Trauma
• Others
• Europe Gelatin and Bone Glue Market, By End User:
• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers
• Europe Gelatin and Bone Glue Market, By Country:
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Company Profiles
• Johnson & Johnson
• Baxter International Inc.
• CryoLife, Inc.
• Becton, Dickinson and Company
• Luna Innovations Incorporated
• Braun Melsungen AG
• Cohera Medical, Inc.
• Integra LifeSciences Corporation
• Tissuemed Ltd.
• Chemence Medical, Inc.